Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea
Clinical trial NCT01215669 · COMPLETED
Trial details
- NCT number
- NCT01215669
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-02-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.